News Ingevity Corporation

Stocks

NGVT

US45688C1071

Diversified Chemicals

Real-time Estimate Cboe BZX 22:20:55 28/10/2026 +04			5-day change	1st Jan Change
73.66 ^USD	-0.71%		+5.06%	+25.50%

08-19	Ingevity Insider Sold Shares Worth $764,673, According to a Recent SEC Filing	MT
07-31	Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026

All News

Mentions Relevance

10-27	Ingevity Celebrates 10 Years as a Public Company with NYSE Closing Bell® Ringing	BU
10-26	NYSE Publishes 'The Busiest Room on Wall Street': NYSE Content Update	PR
10-07	Ingevity announces dates for third quarter 2026 earnings release and webcast	BU
10-07	Ingevity : announces dates for third quarter 2026 earnings release and webcast	PU
09-17	Ingevity CEO Dave Li to speak at 2026 Water Tower Research Insights Conference	BU
09-03	Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference	BU
09-02	An Exclusive License Does Not Automatically Eliminate A Patent Owner’s Right To Sue	AQ
08-19	Ingevity included in TIME America's Best Companies 2026 list	AQ
08-19	Ingevity Insider Sold Shares Worth $764,673, According to a Recent SEC Filing	MT
08-18	Ingevity included in TIME America’s Best Companies 2026 list	BU
08-05	Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact	BU
07-31	Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026
07-30	Ingevity's Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised	MT
07-30	Ingevity: Q2 Earnings Snapshot	AQ
07-30	Earnings Flash (NGVT) Ingevity Corporation Reports Q2 Revenue $314.1M, vs. FactSet Est of $312.2M	MT
07-30	Earnings Flash (NGVT) Ingevity Corporation Posts Q2 Adjusted EPS $1.74 per Share, vs. FactSet Est of $1.33	MT
07-30	Ingevity reports second quarter 2026 financial results	BU
07-30	Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.	CI
07-30	Ingevity Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-16	Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany	CI
07-16	Ingevity’s Evotherm® P35 receives BASt approval in Germany	BU
07-02	Ingevity : announces dates for second quarter 2026 earnings release and webcast	PU
07-02	Ingevity announces dates for second quarter 2026 earnings release and webcast	BU
06-25	Ingevity Names Ryan Cotterman as Chief Accounting Officer	MT
06-25	Ingevity Corporation Appoints Ryan Cotterman as Vice President, Chief Accounting Officer and Principal Accounting Officer, Effective June 22, 2026	CI